Rosacea Facial Redness That Won’t Go Away? Here’s a Treatment That Can Help.

Posted on: Fri, 05/04/2018 - 06:06 By: nrs-admin

Rhofade Did you know ongoing facial redness is the most common sign of rosacea? It usually appears on the cheeks, chin, nose, or forehead. It’s a chronic skin condition that can worsen over time. That’s why it’s so important to talk to your doctor about it.1

There is an FDA-approved treatment for adults with ongoing rosacea facial redness, RHOFADE® (oxymetazoline HCl) cream, 1%. Applied every day, RHOFADE® cream helps tighten specific blood vessels near the surface of your skin to visibly reduce ongoing facial redness.2 Managing your ongoing facial redness with RHOFADE® cream can help you take one step closer to a more normal, healthy skin color.3,4 Learn more and see before and after pictures at Please see Important Safety Information for RHOFADE® below.

Ready to reduce the redness? You could pay as little as $0* for RHOFADE® cream.


RHOFADE® (oxymetazoline HCl) cream 1% is a prescription medicine used on the skin to treat ongoing facial redness due to rosacea in adults.

Before you use RHOFADE® cream, tell your doctor about all your medical conditions, including if you have: heart, blood vessel, or blood pressure problems, or narrow-angle glaucoma (get medical help if these conditions worsen); problems with blood circulation or have had a stroke; Sjögren’s syndrome; scleroderma; Raynaud’s phenomenon; thromboangiitis obliterans; or irritated skin or open sores on the face.

Tell your doctor about your medications, as use with RHOFADE® cream may cause serious side effects.

The most common side effects at the application site include: skin reactions, worsening of rosacea pimples, itching, redness, and pain.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

Please click here for the RHOFADE® cream full Product Information.

1. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584-587.
2. RHOFADE® Prescribing Information 01/2017.
3. Data on file, Allergan, 2015.
4. Data on file, Allergan, 2015.

Allergan logo

All trademarks are the property of their respective owners.
© 2018 Allergan. All rights reserved.
RHO114578 04/18